TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma

<p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppresso...

Full description

Bibliographic Details
Main Authors: Ma Ning, Zhang Jinyan, Lin Longde, Mo Yingxi, Yu Nana, Du Chunping, Huang Tingting, Zhou Xiaoying, Xiao Xue, Wang Shumin, Murata Mariko, Huang Guangwu, Zhang Zhe
Format: Article
Language:English
Published: BMC 2010-11-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/10/617
_version_ 1828814044159541248
author Ma Ning
Zhang Jinyan
Lin Longde
Mo Yingxi
Yu Nana
Du Chunping
Huang Tingting
Zhou Xiaoying
Xiao Xue
Wang Shumin
Murata Mariko
Huang Guangwu
Zhang Zhe
author_facet Ma Ning
Zhang Jinyan
Lin Longde
Mo Yingxi
Yu Nana
Du Chunping
Huang Tingting
Zhou Xiaoying
Xiao Xue
Wang Shumin
Murata Mariko
Huang Guangwu
Zhang Zhe
author_sort Ma Ning
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. In this study, we investigated whether <it>TFPI-2 </it>was inactivated epigenetically in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>Transcriptional expression levels of <it>TFPI-2 </it>was evaluated by RT-PCR. Methylation status were investigated by methylation specific PCR and bisulfate genomic sequencing. The role of <it>TFPI-2 </it>as a tumor suppressor gene in NPC was addressed by re-introducing <it>TFPI-2 </it>expression into the NPC cell line CNE2.</p> <p>Results</p> <p><it>TFPI-2 </it>mRNA transcription was inactivated in NPC cell lines. <it>TFPI-2 </it>was aberrantly methylated in 66.7% (4/6) NPC cell lines and 88.6% (62/70) of NPC primary tumors, but not in normal nasopharyngeal epithelia. <it>TFPI-2 </it>expression could be restored in NPC cells after demethylation treatment. Ectopic expression of TFPI-2 in NPC cells induced apoptosis and inhibited cell proliferation, colony formation and cell migration.</p> <p>Conclusions</p> <p>Epigenetic inactivation of <it>TFPI-2 </it>by promoter hypermethylation is a frequent and tumor specific event in NPC. <it>TFPI-2 </it>might be considering as a putative tumor suppressor gene in NPC.</p>
first_indexed 2024-12-12T10:15:01Z
format Article
id doaj.art-b824109ce93f481292f17b362284abed
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-12-12T10:15:01Z
publishDate 2010-11-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-b824109ce93f481292f17b362284abed2022-12-22T00:27:41ZengBMCBMC Cancer1471-24072010-11-0110161710.1186/1471-2407-10-617TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinomaMa NingZhang JinyanLin LongdeMo YingxiYu NanaDu ChunpingHuang TingtingZhou XiaoyingXiao XueWang ShuminMurata MarikoHuang GuangwuZhang Zhe<p>Abstract</p> <p>Background</p> <p>Epigenetic silencing of tumor suppressor genes play important roles in NPC tumorgenesis. Tissue factor pathway inhibitor-2 (TFPI-2), is a protease inhibitor. Recently, <it>TFPI-2 </it>was suggested to be a tumor suppressor gene involved in tumorigenesis and metastasis in some cancers. In this study, we investigated whether <it>TFPI-2 </it>was inactivated epigenetically in nasopharyngeal carcinoma (NPC).</p> <p>Methods</p> <p>Transcriptional expression levels of <it>TFPI-2 </it>was evaluated by RT-PCR. Methylation status were investigated by methylation specific PCR and bisulfate genomic sequencing. The role of <it>TFPI-2 </it>as a tumor suppressor gene in NPC was addressed by re-introducing <it>TFPI-2 </it>expression into the NPC cell line CNE2.</p> <p>Results</p> <p><it>TFPI-2 </it>mRNA transcription was inactivated in NPC cell lines. <it>TFPI-2 </it>was aberrantly methylated in 66.7% (4/6) NPC cell lines and 88.6% (62/70) of NPC primary tumors, but not in normal nasopharyngeal epithelia. <it>TFPI-2 </it>expression could be restored in NPC cells after demethylation treatment. Ectopic expression of TFPI-2 in NPC cells induced apoptosis and inhibited cell proliferation, colony formation and cell migration.</p> <p>Conclusions</p> <p>Epigenetic inactivation of <it>TFPI-2 </it>by promoter hypermethylation is a frequent and tumor specific event in NPC. <it>TFPI-2 </it>might be considering as a putative tumor suppressor gene in NPC.</p>http://www.biomedcentral.com/1471-2407/10/617
spellingShingle Ma Ning
Zhang Jinyan
Lin Longde
Mo Yingxi
Yu Nana
Du Chunping
Huang Tingting
Zhou Xiaoying
Xiao Xue
Wang Shumin
Murata Mariko
Huang Guangwu
Zhang Zhe
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
BMC Cancer
title TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
title_full TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
title_fullStr TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
title_full_unstemmed TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
title_short TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
title_sort tfpi 2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma
url http://www.biomedcentral.com/1471-2407/10/617
work_keys_str_mv AT maning tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT zhangjinyan tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT linlongde tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT moyingxi tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT yunana tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT duchunping tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT huangtingting tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT zhouxiaoying tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT xiaoxue tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT wangshumin tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT muratamariko tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT huangguangwu tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma
AT zhangzhe tfpi2isaputativetumorsuppressorgenefrequentlyinactivatedbypromoterhypermethylationinnasopharyngealcarcinoma